In the COHERE study patients with Hodgkin lymphoma and who were in receipt of HAART lost 98 CD4 lymphocytes (95% CI, −159 to −36 cells) in the year preceding diagnosis whilst maintaining viral suppression on HAART [13]. This evidence concerns the gene CD4 and Hodgkins lymphoma.